Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
5 papers
Recent·Most cited
X. Wang, W. J. Jowsey, C.-Y. Cheung…·M. B. McNeil
The paper identifies vulnerabilities in isoniazid-resistant Mycobacterium tuberculosis strains by analyzing metabolic and transcriptional changes in katG mutants.
N. J. Waller, C.-Y. Cheung, G. Cook, M. B. McNeil
This study shows that drug resistance in M. tuberculosis can lead to collateral sensitivity to unrelated drugs, offering new strategies to combat drug-resistant strains.
C. D. Shelton, M. B. McNeil, L. Flint…·T. Parish
This study identifies triazolopyrimidines as inhibitors of Mycobacterium tuberculosis cytochrome bc1 complex, showing resistance linked to QcrB mutations and efficacy against intracellular bacteria.
C. R. Adolph, M. B. McNeil, G. M. Cook
This study shows that impaired succinate oxidation in M. tuberculosis prevents growth and affects drug susceptibility by altering respiratory chain activity and drug responses.
M. B. McNeil, S. Chettiar, D. Awasthi, T. Parish
The paper shows that cell wall inhibitors enhance rifampicin accumulation in Mycobacterium tuberculosis by increasing cellular permeability, suggesting potential for improved tuberculosis treatment combinations.